Description: Angiotensin II Receptor Blocker, Antihypertensive
“Alert: Black Box Warning
Avoid use in pregnancy. When pregnancy is detected, discontinue Azilsartan, Edarbi as soon as possible. Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus.”
CSA NA – FDA Approved – REMS (N) – Can Ship
How Does It Work
Azilsartan, Edarbi is an angiotensin II receptor blocker that prevents angiotensin II, a vasoconstricting peptide that also promotes aldosterone release. Azilsartan, Edarbi thereby reduces blood pressure by inhibiting angiotensin II’s vasoconstrictor and aldosterone-secreting effects.
Indications For Use
Before starting Azilsartan, Edarbi makes sure your physician is aware of any allergies or medications you currently take. Azilsartan, Edarbi has been reported to cause angioedema (especially following the first dose), hyperkalemia and deterioration in renal function. Azilsartan, Edarbi should be used with caution in patients with aortic/mitral valve stenosis, renal artery stenosis and renal impairment.
Oral: 40mg to 80mg daily.
Pharmacist Tips On Using
How to Take: Take with or without food.
Diarrhea, hypotension, dizziness, fatigue, orthostatic dizziness, nausea, muscle spasm, cough.
Note this is not a complete list of side effects for Azilsartan, Edarbi only common ones.
Frequently Asked Questions
What do I do if I show signs of high potassium levels (nausea, weakness, irregular heartbeat, tingling sensation, loss of movement)
Seek immediate medical attention, it is a rare but potentially serious side effect of Azilsartan, Edarbi.